Conferences Pharos iBio is attending in 2026
Pharos iBio is listed at 2 conferences on Tnuki's calendar in 2026: ENA 2026 (on the program) and Discovery on Target 2026 (on the attendee list). Pharos iBio is a drug developer using an AI discovery platform; its lead candidate lasmotinib (PHI-101) targets acute myeloid leukemia. As of Oct 20, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsCancer drug discovery & early-development scientistsOfficial site |
Barcelona, Spain ~1.5k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 poster
|
Open the guide Search and filter attendees |
Discovery on Target 2026Target discovery biologists & chemistsOfficial site |
Past Boston, MA ~1.1k attendees | On the attendee listNo booth or sponsorship in the organizer’s published lists Listed in the Discovery on Target 2026 guide; no booth or program details yet
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Pharos iBio’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Pharos iBio
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!